Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two‐center study

Author:

Ni Wenjie1,Chen Junqiang2,Xiao Zefen1,Yu Shufei3,Zhang Wencheng4,Zhou Zongmei1,Chen Dongfu1,Feng Qinfu1,Chen Xiaohui5,Lin Yu2,Zhu Kunshou5,Gao Shugeng6,Xue Qi6,Mao Yousheng6,Cheng Guiyu6,Sun Kelin6,Liu Xiangyang6,Fang Dekang6

Affiliation:

1. Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Department of Radiation Oncology Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou China

3. Department of Radiotherapy Beijing Chao‐yang Hospital, Capital Medical University Beijing China

4. Department of Radiation Oncology Tianjing Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer Tianjin China

5. Department of Thoracic Surgery Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou China

6. Department of Thoracic Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Funder

Beijing Hope Run Special Fund of Cancer Foundation of China

Capital Clinical Characteristic Application Research of China

Capital Fund for Health Improvement and Research

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3